8-K
Current Report
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-24-157521
Material agreement
- Item 1.01 Entry into a material definitive agreement
From the SEC's structured data for this filing
Loading d835355d8k.htm…
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-24-157521
Material agreement
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…